Trial Profile
A Randomized, Placebo-Controlled Study To Evaluate The Efficacy, Safety And Tolerability Of CP-533,536 In Subjects With Closed Fracture Of The Tibial Shaft
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2014
Price :
$35
*
At a glance
- Drugs Evatanepag (Primary)
- Indications Fracture
- Focus Therapeutic Use
- Acronyms ACTiF
- Sponsors Pfizer
- 30 May 2014 New trial record